Endobiont Viruses Sensed by the Human Host - Beyond Conventional Antiparasitic Therapy

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Fichorova, Raina N ^a   Lee, Yujin ^a   Yamamoto, Hidemi S ^a   Takagi, Yuko ^b   Hayes, Gary R ^c   Goodman, Russell P ^a,b   Chepa Lotrea, Xenia ^a,d   Buck, Olivia R ^a   Murray, Ryan ^a,e   Kula, Tomasz ^b   Beach, David H ^c   Singh, Bibhuti N ^c   Nibert, Max L ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; DOUBLE STRANDED RNA; INTERFERON; INTERFERON REGULATORY FACTOR 3; METRONIDAZOLE; TOLL LIKE RECEPTOR 3;

ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; ENDOSYMBIONT; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION SENSITIVITY; INFLAMMATION; NONHUMAN; PARASITE ISOLATION; PREMATURE LABOR; RNA VIRUS; TRICHOMONAS VAGINALIS; TRICHOMONASVIRUS; TRICHOMONIASIS; VIRUS CELL INTERACTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPARASITIC AGENTS; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERFERON REGULATORY FACTOR-3; METRONIDAZOLE; MODELS, BIOLOGICAL; PARASITES; RIBONUCLEASE III; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; SYMBIOSIS; TOLL-LIKE RECEPTOR 3; TOTIVIRIDAE; TRICHOMONAS VAGINALIS; VAGINA; VIRION; VIRUS DISEASES;

DSRNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS; PROTOZOA; TRICHOMONAS VAGINALIS;

EID: 84868695257     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048418     Document Type: Article

References (64)

1. Wang AL, Wang CC, (1991) Viruses of the protozoa. Annu Rev Microbiol 45: 251-263.
2. Goodman RP, Ghabrial SA, Fichorova RN, Nibert ML, (2011) Trichomonasvirus: a new genus of protozoan viruses in the family Totiviridae. Arch Virol 156: 171-179.
3. Fichorova RN, (2009) Impact of T. vaginalis infection on innate immune responses and reproductive outcome. J Reprod Immunol 83: 185-189.
4. Gülmezoglu AM, Azhar M (2011) Interventions for trichomoniasis in pregnancy. Cochrane Database of Systematic Reviews (Online) Issue 5 Art No: CD000220.
5. Shafir SC, Sorvillo FJ, Smith L, (2009) Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev 22: 37-45.
6. John CC, Nduatti RW, Mbori-Ngacha DA, (2001) Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission:association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding and breast infections. J Inf Dis 183: 206-212.
7. Grodstein F, Goldman MB, Cramer DW, (1993) Relation of tubal infertility to history of sexually transmitted diseases. Am J Epidemiol 137: 577-584.
8. Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD, (2005) Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis 192: 2039-2044.
9. Viikki M, Pukkala E, Nieminen P, Hakama M, (2000) Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol 39: 71-75.
10. McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, et al. (2007) Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 195: 698-702.
11. Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, et al. (2009) Prospective Study of Trichomonas vaginalis Infection and Prostate Cancer Incidence and Mortality: Physicians' Health Study. J Natl Cancer Inst 101: 1406-1411.
12. Chesson HW, Blandford JM, Pinkerton SD, (2004) Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex Transm Dis 31: 547-551.
13. Okun N, Gronau KA, Hannah ME, (2005) Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 105: 857-868.
14. Petrin D, Delgaty K, Bhatt R, Garber G, (1998) Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 11: 300-317.
15. Feola DJ, Thornton AC, (2002) Metronidazole-induced pancreatitis in a patient with recurrent vaginal trichomoniasis. Pharmacotherapy 22: 1508-1510.
16. Secor WE, (2012) Trichomonas vaginalis: treatment questions and challenges. Expert Review of Anti-infective Therapy 10: 107-109.
17. Goodman RP, Freret TS, Kula T, Geller AM, Talkington MW, et al. (2011) Clinical isolates of Trichomonas vaginalis concurrently infected by strains of up to four Trichomonasvirus species (Family Totiviridae). J Virol 85: 4258-4270.
18. Wendel KA, Rompalo AM, Erbelding EJ, Chang TH, Alderete JF, (2002) Double-Stranded RNA Viral Infection of Trichomonas vaginalis Infecting Patients Attending a Sexually Transmitted Diseases Clinic. J Infect Dis 186: 558-561.
19. Fraga J, Rojas L, Sariego I, Fernández-Calienes A, (2012) Genetic characterization of three Cuban Trichomonas vaginalis virus. Phylogeny of Totiviridae family. Infection, Genetics and Evolution 12: 113-120.
20. Bessarab IN, Liu H-W, Ip C-F, Tai J-H, (2000) The complete cDNA sequence of a Type II Trichomonas vaginalis virus. Virology 267: 350-359.
21. Weber B, Mapeka TM, Maahlo MA, Hoosen AA, (2003) Double stranded RNA virus in South African Trichomonas vaginalis isolates. J Clin Pathol 56: 542-543.
22. Fichorova RN, Trifonova RT, Gilbert RO, Costello CE, Hayes GR, et al. (2006) Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun 74: 5773-5779.
23. Singh BN, Hayes GR, Lucas JJ, Sommer U, Viseux N, et al. (2009) Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function. Glycoconj J 26: 3-17.
24. Fichorova RN, Rheinwald JG, Anderson DJ, (1997) Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod 57: 847-855.
25. Trifonova RT, Pasicznyk JM, Fichorova RN, (2006) Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo. Antimicrob Agents Chemother 50: 4005-4010.
26. Fichorova RN, Yamamoto HS, Delaney ML, Onderdonk AB, Doncel GF, (2011) Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio 2: e00168-00111.
27. Upcroft JA, Upcroft P, (2001) Drug susceptibility testing of anaerobic protozoa. Antimicrob Agents Chemother 45: 1810-1814.
28. Fichorova RN, Richardson-Harman N, Alfano M, Belec L, Carbonneil C, et al. (2008) Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem 80: 4741-4751.
29. Martel RR, Botros IW, Rounseville MP, Hinton JP, Staples RR, et al. (2002) Multiplexed screening assay for mRNA combining nuclease protection with luminescent array detection. Assay Drug Dev Technol 1: 61-71.
30. Bhattacharyya S, Ghosh S, Sen P, Roy S, Majumdar S, (2001) Selective impairment of protein kinase C isotypes in murine macrophage by Leishmania donovani. Mol Cell Biochem 216: 47-57.
31. Rodriguez N, Yang J, Hasselblatt K, Liu S, Zhou Y, et al. (2012) Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells. EMBO Mol Med 4: 952-963.
32. Wira CR, Grant-Tschudy KS, Crane-Godreau MA, (2005) Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am J Reprod Immunol 53: 65-76.
33. Carlton JM, Hirt RP, Silva JC, Delcher AL, Schatz M, et al. (2007) Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 315: 207-212.
34. Fichorova RN, Anderson DJ, (1999) Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 60: 508-514.
35. Fichorova RN, Tucker LD, Anderson DJ, (2001) The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 184: 418-428.
36. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR, (2002) Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol 168: 2424-2432.
37. Canny GO, Trifonova RT, Kindelberger DW, Colgan SP, Fichorova RN, (2006) Expression and function of bactericidal/permeability-increasing protein in human genital tract epithelial cells. J Infect Dis 194: 498-502.
38. Ayehunie S, Cannon C, Lamore S, Kubilus J, Anderson DJ, et al. (2006) Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and feminine-care products. Toxicology in Vitro 20: 689-698.
39. Sin W-X, Li P, Yeong J, Chin K-C, (2012) Activation and regulation of interferon-β in immune responses. Immunol Res 53: 25-40.
40. Draper D, Donohoe W, Mortimer L, Heine RP, (1998) Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor. J Infect Dis 178: 815-819.
41. Fichorova RN, Desai PJ, Gibson FC 3rd, Genco CA (2001) Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun 69: 5840-5848.
42. Yu M, Levine SJ, (2011) Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: Key modulators of innate immune responses to double-stranded RNA viruses. Cytokine & Growth Factor Reviews 22: 63-72.
43. Andersen JM, Al-Khairy D, Ingalls RR, (2006) Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol Reprod 74: 824-831.
44. Trifonova RT, Doncel GF, Fichorova RN, (2009) Polyanionic microbicides modify TLR-mediated cervicovaginal immune responses. Antimicrob Agents Chemother 53: 1490-1500.
45. Kuznik A, Bencina M, Svajger U, Jeras M, Rozman B, et al. (2011) Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J Immunol 186: 4794-4804.
46. Sen GC, Sarkar SN, (2005) Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev 16: 1-14.
47. Fichorova RN, Lai JJ, Schwartz JL, Weiner DH, Mauck CK, et al. (2011) Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non-pregnant women in microbicide trials. Cytokine 55: 134-140.
48. Khoshnan A, Alderete JF, (1994) Trichomonas vaginalis with a double-stranded RNA virus has upregulated levels of phenotypically variable immunogen mRNA. J Virol 68: 4035-4038.
49. Ives A, Ronet C, Prevel F, Ruzzante G, Fuertes-Marraco S, et al. (2011) Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science 331: 775-778.
50. Fraga J, Rojas L, Sariego I, Fernandez-Calienes A, Nunez FA, (2007) Double-stranded RNA viral infection of Trichomonas vaginalis and association with clinical presentation. Acta protozoologica 46: 93-98.
51. Alfano M, Poli G, (2002) The cytokine network in HIV infection. Curr Mol Med 2: 677-689.
52. Fichorova RN, (2004) Guiding the vaginal microbicide trials with biomarkers of inflammation. J Acquir Immune Defic Syndr 37Suppl 3: S184-193.
53. Ghosh M, Shen Z, Schaefer TM, Fahey JV, Gupta P, et al. (2009) CCL20/MIP3α is a Novel Anti-HIV-1 Molecule of the Human Female Reproductive Tract. American Journal of Reproductive Immunology 62: 60-71.
54. Iqbal SM, Ball TB, Kimani J, Kiama P, Thottingal P, et al. (2005) Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. J Infect Dis 192: 728-738.
55. Iversen AKN, Fugger L, Eugen-Olsen J, Balslev U, Jensen T, et al. (1998) Cervical Human Immunodeficiency Virus Type 1 Shedding is Associated with Genital Î2-Chemokine Secretion. The Journal of Infectious Diseases 178: 1334-1342.
56. Polo S, Veglia F, Malnati MS, Gobbi C, Farci P, et al. (1999) Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection. AIDS 13: 447-454.
57. Flegr J, Cerkasov J, Kulda J, Tachezy J, Stokrova J, (1987) The dsRNA of Trichomonas vaginalis is associated with virus like particles and does not correlate with metronidazole resistance. Folia Microbiol (Praha) 32: 345-348.
58. Snipes LJ, Gamard PM, Narcisi EM, Beard CB, Lehmann T, et al. (2000) Molecular Epidemiology of Metronidazole Resistance in a Population of Trichomonas vaginalis Clinical Isolates. JCM 38: 3004-3009.
59. Jun JK, Yoon BH, Romero R, Kim M, Moon JB, et al. (2000) Interleukin 6 determinations in cervical fluid have diagnostic and prognostic value in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 183: 868-873.
60. Genc MR, Witkin SS, Delaney ML, Paraskevas LR, Tuomala RE, et al. (2004) A disproportionate increase in IL-1beta over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstet Gynecol 190: 1191-1197.
61. Fichorova RN, Onderdonk AB, Yamamoto H, Delaney ML, DuBois AM, et al. (2011) Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. MBio 2: e00280-00210.
62. Faupel-Badger JM, Fichorova RN, Allred EN, Hecht JL, Dammann O, et al. (2011) Cluster Analysis of Placental Inflammatory Proteins can Distinguish Preeclampsia from Preterm Labor and Premature Membrane Rupture in Singleton Deliveries Less Than 28 Weeks of Gestation. Am J Reprod Immunol.
63. Edwards DI, (1979) Mechanism of antimicrobial action of metronidazole. J Antimicrob Chemother 5: 499-502.
64. Wood BA, Monro AM (1975) Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses. Br J Vener Dis 51(1) 51-53.